Gary Nabors
Corporate Officer/Principal presso APPILI THERAPEUTICS INC.
Profilo
Gary S.
Nabors currently works at DynPort Vaccine Co. LLC, as President and Appili Therapeutics, Inc., as Chief Development Officer from 2023.
Dr. Nabors also formerly worked at Biotherapeutics, Inc., as Chief Development Officer & Executive VP.
Posizioni attive di Gary Nabors
| Società | Posizione | Inizio |
|---|---|---|
| APPILI THERAPEUTICS INC. | Corporate Officer/Principal | 03/04/2023 |
DynPort Vaccine Co. LLC
 DynPort Vaccine Co. LLC Miscellaneous Commercial ServicesCommercial Services DynPort Vaccine Co. LLC develops vaccines, biologic products and small molecule anti-infectives. It provides its products and services to the defense and military sectors in the United States. The company was founded in 1997 by Zsolt Pál Harsányi and is headquartered in Reston, VA. | Presidente | - |
Precedenti posizioni note di Gary Nabors
| Società | Posizione | Fine |
|---|---|---|
Biotherapeutics, Inc.
 Biotherapeutics, Inc. BiotechnologyHealth Technology Biotherapeutics, Inc. operates as a pre-clinical stage company which develops small-molecule drugs to treat inflammation and type 2 diabetes. Its scientific foundation is anchored on informatics and computer modeling-enabled drug development with significant animal pharmacology validation. The company was founded by Josep Bassaganya-Riera in 2008 and is headquartered in Blacksburg, VA. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| APPILI THERAPEUTICS INC. | Health Technology |
| Aziende private | 2 |
|---|---|
DynPort Vaccine Co. LLC
DynPort Vaccine Co. LLC Miscellaneous Commercial ServicesCommercial Services DynPort Vaccine Co. LLC develops vaccines, biologic products and small molecule anti-infectives. It provides its products and services to the defense and military sectors in the United States. The company was founded in 1997 by Zsolt Pál Harsányi and is headquartered in Reston, VA. | Commercial Services |
Biotherapeutics, Inc.
Biotherapeutics, Inc. BiotechnologyHealth Technology Biotherapeutics, Inc. operates as a pre-clinical stage company which develops small-molecule drugs to treat inflammation and type 2 diabetes. Its scientific foundation is anchored on informatics and computer modeling-enabled drug development with significant animal pharmacology validation. The company was founded by Josep Bassaganya-Riera in 2008 and is headquartered in Blacksburg, VA. | Health Technology |
- Borsa valori
- Insiders
- Gary Nabors
